BioSpace News Archive

AVROBIO is switching priorities in 2022 away from its Fabry disease program and into its other more lucrative clinical-stage projects.

More than 103,000 people in the U.S. were hospitalized on January 3, 2022, for COVID-19—the highest daily figure of hospitalizations since last summer when the Delta variant emerged.

The novelty of this technique lies in the capture of an intermediate state during the conversion of glial cells into neurons.

Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), today announced first-in-human cases of pulsed field cryoablation (PFCA) for the treatment of atrial fibrillation (AF).

BIORCHESTRA and SK Biopharmaceuticals announced today that they have forged a partnership to research and develop new therapeutic compounds targeting microRNAs [1] (miRNA) for a potential treatment of epilepsy.

Eargo, Inc., a medical device company on a mission to improve the quality of life of people with hearing loss, launched Eargo 6, its sixth-generation FDA Class II exempt hearing aid and most powerful device yet, at CES 2022.

Accro Bioscience Co., LTD., a China-based leading biotechnology company, announced that the company has recently raised over $50 million in an oversubscribed Series B round.

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the 40th Annual J.P. Morgan Healthcare Conference to be held virtually on Wednesday, January 12, 2022.

Geron Corporation announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, will present a company overview at the H.C. Wainwright BioConnect Conference.

ImmunoGenesis announced that President and CEO James Barlow will present on the company and its multiple immune-oncology therapeutic development programs targeting immune-excluded cold cancers at Biotech Showcase 2022, which runs during “JP Morgan Healthcare Week.” Barlow’s presentation will be on Monday, January 10, at 2:30 pm PST.